{"count": 10, "results": [{"_id": "37772313", "pmid": 37772313, "title": "Metabolomic analysis of serum samples from a clinical study on ipragliflozin and metformin treatment in Japanese patients with type 2 diabetes: Exploring human metabolites associated with visceral fat reduction.", "journal": "Pharmacotherapy", "authors": ["Tsukagoshi-Yamaguchi A", "Koshizaka M", "Ishibashi R", "Ishikawa K", "Ishikawa T", "Shoji M", "Ide S", "Ide K", "Baba Y", "Terayama R", "Hattori A", "Takemoto M", "Ouchi Y", "Maezawa Y", "Yokote K", "PRIME-V study group"], "date": "2023-09-29T00:00:00Z", "doi": "10.1002/phar.2884", "meta_date_publication": "2023 Sep 29", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50255.656, "text_hl": "Metabolomic analysis of serum samples from a clinical study on @CHEMICAL_ipragliflozin @CHEMICAL_MESH:C572941 @@@ipragliflozin@@@ and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ treatment in Japanese patients with @DISEASE_Diabetes_Mellitus_Type_2 @DISEASE_MESH:D003924 @@@type 2 diabetes@@@: Exploring human metabolites associated with @<m>DISEASE_Intestinal_Pseudo_Obstruction</m> @DISEASE_MESH:D007418 @@@visceral fat reduction@@@.", "citations": {"NLM": "Tsukagoshi-Yamaguchi A, Koshizaka M, Ishibashi R, Ishikawa K, Ishikawa T, Shoji M, Ide S, Ide K, Baba Y, Terayama R, Hattori A, Takemoto M, Ouchi Y, Maezawa Y, Yokote K, PRIME-V study group. Metabolomic analysis of serum samples from a clinical study on ipragliflozin and metformin treatment in Japanese patients with type 2 diabetes: Exploring human metabolites associated with visceral fat reduction. Pharmacotherapy. 2023 Sep 29;():. PMID: 37772313", "BibTeX": "@article{37772313, title={Metabolomic analysis of serum samples from a clinical study on ipragliflozin and metformin treatment in Japanese patients with type 2 diabetes: Exploring human metabolites associated with visceral fat reduction.}, author={Tsukagoshi-Yamaguchi A and Koshizaka M and Ishibashi R and Ishikawa K and Ishikawa T and Shoji M and Ide S and Ide K and Baba Y and Terayama R and Hattori A and Takemoto M and Ouchi Y and Maezawa Y and Yokote K and PRIME-V study group}, journal={Pharmacotherapy}}"}}, {"_id": "34779790", "pmid": 34779790, "title": "Is Metformin Use Associated with Prolonged Overall Survival in Patients with Soft Tissue Sarcoma? A SEER-Medicare Study.", "journal": "Clin Orthop Relat Res", "authors": ["Hutchinson ID", "Ata A", "DiCaprio MR"], "date": "2022-04-01T00:00:00Z", "doi": "10.1097/CORR.0000000000002045", "meta_date_publication": "2022 Apr 1", "meta_volume": "480", "meta_issue": "4", "meta_pages": "735-744", "score": 50242.56, "text_hl": "...BACKGROUND: @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@, an oral drug used to treat @SPECIES_9606 @@@patients@@@ with @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes@@@, has been associated with prolonged survival in @SPECIES_9606 @@@patients@@@ with various @<m>DISEASE_Intestinal_Pseudo_Obstruction</m> @DISEASE_MESH:D007418 @@@visceral carcinomas@@@. ", "citations": {"NLM": "Hutchinson ID, Ata A, DiCaprio MR. Is Metformin Use Associated with Prolonged Overall Survival in Patients with Soft Tissue Sarcoma? A SEER-Medicare Study. Clin Orthop Relat Res. 2022 Apr 1;480(4):735-744. PMID: 34779790", "BibTeX": "@article{34779790, title={Is Metformin Use Associated with Prolonged Overall Survival in Patients with Soft Tissue Sarcoma? A SEER-Medicare Study.}, author={Hutchinson ID and Ata A and DiCaprio MR}, journal={Clin Orthop Relat Res}, volume={480}, number={4}, pages={735-744}}"}}, {"_id": "19496972", "pmid": 19496972, "title": "Metformin therapy to reduce weight gain and visceral adiposity in children and adolescents with neurogenic or myogenic motor deficit.", "journal": "Pediatr Diabetes", "authors": ["Casteels K", "Fieuws S", "van Helvoirt M", "Verpoorten C", "Goemans N", "Coudyzer W", "Loeckx D", "de Zegher F"], "date": "2010-02-01T00:00:00Z", "doi": "10.1111/j.1399-5448.2009.00512.x", "meta_date_publication": "2010 Feb", "meta_volume": "11", "meta_issue": "1", "meta_pages": "61-9", "score": 50060.633, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ therapy to reduce @DISEASE_Weight_Gain @DISEASE_MESH:D015430 @@@weight gain@@@ and @<m>DISEASE_Intestinal_Pseudo_Obstruction</m> @DISEASE_MESH:D007418 @@@visceral adiposity@@@ in children and adolescents with @DISEASE_Communication_Disorders @DISEASE_MESH:D003147 @@@neurogenic or myogenic motor deficit@@@.", "citations": {"NLM": "Casteels K, Fieuws S, van Helvoirt M, Verpoorten C, Goemans N, Coudyzer W, Loeckx D, de Zegher F. Metformin therapy to reduce weight gain and visceral adiposity in children and adolescents with neurogenic or myogenic motor deficit. Pediatr Diabetes. 2010 Feb;11(1):61-9. PMID: 19496972", "BibTeX": "@article{19496972, title={Metformin therapy to reduce weight gain and visceral adiposity in children and adolescents with neurogenic or myogenic motor deficit.}, author={Casteels K and Fieuws S and van Helvoirt M and Verpoorten C and Goemans N and Coudyzer W and Loeckx D and de Zegher F}, journal={Pediatr Diabetes}, volume={11}, number={1}, pages={61-9}}"}}, {"_id": "31821361", "pmid": 31821361, "pmcid": "PMC6903728", "title": "Effects of metformin administration on endocrine-metabolic parameters, visceral adiposity and cardiovascular risk factors in children with obesity and risk markers for metabolic syndrome: A pilot study", "journal": "PLoS One", "authors": ["Bassols J", "Martínez-Calcerrada JM", "Osiniri I", "Díaz-Roldán F", "Xargay-Torrent S", "Mas-Parés B", "Dorado-Ceballos E", "Prats-Puig A", "Carreras-Badosa G", "de Zegher F", "Ibáñez L", "López-Bermejo A"], "date": "2019-12-10T00:00:00Z", "doi": "10.1371/journal.pone.0226303", "meta_date_publication": "2019", "meta_volume": "14", "meta_issue": "12", "meta_pages": "e0226303", "score": 50056.387, "text_hl": "Effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ administration on endocrine-metabolic parameters, @<m>DISEASE_Intestinal_Pseudo_Obstruction</m> @DISEASE_MESH:D007418 @@@visceral adiposity@@@ and cardiovascular risk factors in children with @DISEASE_Obesity @DISEASE_MESH:D009765 @@@obesity@@@ and risk markers for @DISEASE_Metabolic_Syndrome @DISEASE_MESH:D024821 @@@metabolic syndrome@@@: A pilot study", "citations": {"NLM": "Bassols J, Martínez-Calcerrada JM, Osiniri I, Díaz-Roldán F, Xargay-Torrent S, Mas-Parés B, Dorado-Ceballos E, Prats-Puig A, Carreras-Badosa G, de Zegher F, Ibáñez L, López-Bermejo A. Effects of metformin administration on endocrine-metabolic parameters, visceral adiposity and cardiovascular risk factors in children with obesity and risk markers for metabolic syndrome: A pilot study PLoS One. 2019;14(12):e0226303. PMID: 31821361", "BibTeX": "@article{31821361, title={Effects of metformin administration on endocrine-metabolic parameters, visceral adiposity and cardiovascular risk factors in children with obesity and risk markers for metabolic syndrome: A pilot study}, author={Bassols J and Martínez-Calcerrada JM and Osiniri I and Díaz-Roldán F and Xargay-Torrent S and Mas-Parés B and Dorado-Ceballos E and Prats-Puig A and Carreras-Badosa G and de Zegher F and Ibáñez L and López-Bermejo A}, journal={PLoS One}, volume={14}, number={12}, pages={e0226303}}"}}, {"_id": "16381638", "pmid": 16381638, "title": "[Effects of metformin on fatty liver in insulin-resistant rats].", "journal": "Zhonghua Gan Zang Bing Za Zhi", "authors": ["Chen SQ", "Liu Q", "Sun H", "Tang L", "Deng JC"], "date": "2005-12-01T00:00:00Z", "meta_date_publication": "2005 Dec", "meta_volume": "13", "meta_issue": "12", "meta_pages": "915-8", "score": 50052.7, "text_hl": "RESULTS: Compared with the model group, the @DISEASE_Insulin_Resistance @DISEASE_MESH:D007333 @@@insulin resistance@@@, liver index, @<m>DISEASE_Intestinal_Pseudo_Obstruction</m> @DISEASE_MESH:D007418 @@@visceral adiposity@@@ and @DISEASE_Weight_Loss @DISEASE_MESH:D015431 @@@weight loss@@@ of the @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ group were dramatically ameliorated. ", "citations": {"NLM": "Chen SQ, Liu Q, Sun H, Tang L, Deng JC. [Effects of metformin on fatty liver in insulin-resistant rats]. Zhonghua Gan Zang Bing Za Zhi. 2005 Dec;13(12):915-8. PMID: 16381638", "BibTeX": "@article{16381638, title={[Effects of metformin on fatty liver in insulin-resistant rats].}, author={Chen SQ and Liu Q and Sun H and Tang L and Deng JC}, journal={Zhonghua Gan Zang Bing Za Zhi}, volume={13}, number={12}, pages={915-8}}"}}, {"_id": "20216906", "pmid": 20216906, "title": "Epidemiology, assessment, and management of excess abdominal fat in persons with HIV infection.", "journal": "AIDS Rev", "authors": ["Moyle G", "Moutschen M", "Martínez E", "Domingo P", "Guaraldi G", "Raffi F", "Behrens G", "Reiss P"], "date": "2010-01-01T00:00:00Z", "meta_date_publication": "2010 Jan-Mar", "meta_volume": "12", "meta_issue": "1", "meta_pages": "3-14", "score": 50048.117, "text_hl": "In summary, the prevention and management of @<m>DISEASE_Intestinal_Pseudo_Obstruction</m> @DISEASE_MESH:D007418 @@@visceral adiposity@@@ remains a substantial challenge in clinical practice.", "citations": {"NLM": "Moyle G, Moutschen M, Martínez E, Domingo P, Guaraldi G, Raffi F, Behrens G, Reiss P. Epidemiology, assessment, and management of excess abdominal fat in persons with HIV infection. AIDS Rev. 2010 Jan-Mar;12(1):3-14. PMID: 20216906", "BibTeX": "@article{20216906, title={Epidemiology, assessment, and management of excess abdominal fat in persons with HIV infection.}, author={Moyle G and Moutschen M and Martínez E and Domingo P and Guaraldi G and Raffi F and Behrens G and Reiss P}, journal={AIDS Rev}, volume={12}, number={1}, pages={3-14}}"}}, {"_id": "23391573", "pmid": 23391573, "title": "Metformin decreases meal size and number and increases c-Fos expression in the nucleus tractus solitarius of obese mice.", "journal": "Physiol Behav", "authors": ["Kim HJ", "Zhang XH", "Park EY", "Shin KH", "Choi SH", "Chun BG", "Kim DH"], "date": "2013-02-17T00:00:00Z", "doi": "10.1016/j.physbeh.2013.01.011", "meta_date_publication": "2013 Feb 17", "meta_volume": "110-111", "meta_issue": "", "meta_pages": "213-20", "score": 50047.426, "text_hl": "These results indicate that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@-induced @DISEASE_Weight_Loss @DISEASE_MESH:D015431 @@@weight loss@@@ is associated with a sustained reduction in energy intake maintained by a reduction in meal size and number, and that oral administration of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ causes @<m>DISEASE_Intestinal_Pseudo_Obstruction</m> @DISEASE_MESH:D007418 @@@visceral illness@@@ and neuronal activation in the NTS.", "citations": {"NLM": "Kim HJ, Zhang XH, Park EY, Shin KH, Choi SH, Chun BG, Kim DH. Metformin decreases meal size and number and increases c-Fos expression in the nucleus tractus solitarius of obese mice. Physiol Behav. 2013 Feb 17;110-111():213-20. PMID: 23391573", "BibTeX": "@article{23391573, title={Metformin decreases meal size and number and increases c-Fos expression in the nucleus tractus solitarius of obese mice.}, author={Kim HJ and Zhang XH and Park EY and Shin KH and Choi SH and Chun BG and Kim DH}, journal={Physiol Behav}, volume={110-111}, pages={213-20}}"}}, {"_id": "18031315", "pmid": 18031315, "title": "Pioglitazone (7.5 mg/day) added to flutamide-metformin in women with androgen excess: additional increments of visfatin and high molecular weight adiponectin.", "journal": "Clin Endocrinol (Oxf)", "authors": ["Ibáñez L", "López-Bermejo A", "Díaz M", "Enríquez G", "Valls C", "de Zegher F"], "date": "2008-02-01T00:00:00Z", "doi": "10.1111/j.1365-2265.2007.03137.x", "meta_date_publication": "2008 Feb", "meta_volume": "68", "meta_issue": "2", "meta_pages": "317-20", "score": 50047.176, "text_hl": "BACKGROUND AND AIM: Low-dose @CHEMICAL_Pioglitazone @CHEMICAL_MESH:D000077205 @@@pioglitazone@@@ (@CHEMICAL_Pioglitazone @CHEMICAL_MESH:D000077205 @@@Pio@@@), @CHEMICAL_Flutamide @CHEMICAL_MESH:D005485 @@@flutamide@@@ (@CHEMICAL_Flutamide @CHEMICAL_MESH:D005485 @@@Flu@@@), @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ (@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Met@@@) plus an oestro-progestagen is a novel polytherapy lowering total and @<m>DISEASE_Intestinal_Pseudo_Obstruction</m> @DISEASE_MESH:D007418 @@@visceral adiposity@@@, and reducing carotid intima media thickness (IMT) in hyperinsulinaemic @SPECIES_9606 @@@women@@@ with @DISEASE_Virilism @DISEASE_MESH:D014770 @@@androgen excess@@@, without changing their body mass index (BMI). ", "citations": {"NLM": "Ibáñez L, López-Bermejo A, Díaz M, Enríquez G, Valls C, de Zegher F. Pioglitazone (7.5 mg/day) added to flutamide-metformin in women with androgen excess: additional increments of visfatin and high molecular weight adiponectin. Clin Endocrinol (Oxf). 2008 Feb;68(2):317-20. PMID: 18031315", "BibTeX": "@article{18031315, title={Pioglitazone (7.5 mg/day) added to flutamide-metformin in women with androgen excess: additional increments of visfatin and high molecular weight adiponectin.}, author={Ibáñez L and López-Bermejo A and Díaz M and Enríquez G and Valls C and de Zegher F}, journal={Clin Endocrinol (Oxf)}, volume={68}, number={2}, pages={317-20}}"}}, {"_id": "26972495", "pmid": 26972495, "title": "Rutaecarpine ameliorates hyperlipidemia and hyperglycemia in fat-fed, streptozotocin-treated rats via regulating the IRS-1/PI3K/Akt and AMPK/ACC2 signaling pathways.", "journal": "Acta Pharmacol Sin", "authors": ["Nie XQ", "Chen HH", "Zhang JY", "Zhang YJ", "Yang JW", "Pan HJ", "Song WX", "Murad F", "He YQ", "Bian K"], "date": "2016-04-01T00:00:00Z", "doi": "10.1038/aps.2015.167", "meta_date_publication": "2016 Apr", "meta_volume": "37", "meta_issue": "4", "meta_pages": "483-96", "score": 50040.547, "text_hl": "RESULTS: Administration of @CHEMICAL_rutecarpine @CHEMICAL_MESH:C028632 @@@rutaecarpine@@@ or @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ significantly decreased @DISEASE_Obesity @DISEASE_MESH:D009765 @@@obesity@@@, @<m>DISEASE_Intestinal_Pseudo_Obstruction</m> @DISEASE_MESH:D007418 @@@visceral fat@@@ accumulation, water consumption, and serum @CHEMICAL_Technetium @CHEMICAL_MESH:D013667 @@@TC@@@, @CHEMICAL_Thioguanine @CHEMICAL_MESH:D013866 @@@TG@@@ and LDL-cholesterol levels in fat-fed, @CHEMICAL_Streptozocin @CHEMICAL_MESH:D013311 @@@streptozotocin@@@-treated @SPECIES_10116 @@@rats@@@. ", "citations": {"NLM": "Nie XQ, Chen HH, Zhang JY, Zhang YJ, Yang JW, Pan HJ, Song WX, Murad F, He YQ, Bian K. Rutaecarpine ameliorates hyperlipidemia and hyperglycemia in fat-fed, streptozotocin-treated rats via regulating the IRS-1/PI3K/Akt and AMPK/ACC2 signaling pathways. Acta Pharmacol Sin. 2016 Apr;37(4):483-96. PMID: 26972495", "BibTeX": "@article{26972495, title={Rutaecarpine ameliorates hyperlipidemia and hyperglycemia in fat-fed, streptozotocin-treated rats via regulating the IRS-1/PI3K/Akt and AMPK/ACC2 signaling pathways.}, author={Nie XQ and Chen HH and Zhang JY and Zhang YJ and Yang JW and Pan HJ and Song WX and Murad F and He YQ and Bian K}, journal={Acta Pharmacol Sin}, volume={37}, number={4}, pages={483-96}}"}}, {"_id": "15046183", "pmid": 15046183, "title": "Non-alcoholic fatty liver and insulin resistance: a cause-effect relationship?", "journal": "Dig Liver Dis", "authors": ["Bugianesi E", "Zannoni C", "Vanni E", "Marzocchi R", "Marchesini G"], "date": "2004-03-01T00:00:00Z", "doi": "10.1016/j.dld.2003.12.008", "meta_date_publication": "2004 Mar", "meta_volume": "36", "meta_issue": "3", "meta_pages": "165-73", "score": 50036.168, "text_hl": "@DISEASE_Insulin_Resistance @DISEASE_MESH:D007333 @@@Insulin resistance@@@ provides a target for specific treatment of @DISEASE_Non_alcoholic_Fatty_Liver_Disease @DISEASE_MESH:D065626 @@@non-alcoholic fatty liver@@@, and @GENE_INS @GENE_3630 @@@insulin@@@-sensitising agents (@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ or @CHEMICAL_Thiazolidinediones @CHEMICAL_MESH:D045162 @@@thiazolidinediones@@@) as well as lifestyle changes to reduce @<m>DISEASE_Intestinal_Pseudo_Obstruction</m> @DISEASE_MESH:D007418 @@@visceral adiposity@@@ are the most promising therapeutic options. ", "citations": {"NLM": "Bugianesi E, Zannoni C, Vanni E, Marzocchi R, Marchesini G. Non-alcoholic fatty liver and insulin resistance: a cause-effect relationship? Dig Liver Dis. 2004 Mar;36(3):165-73. PMID: 15046183", "BibTeX": "@article{15046183, title={Non-alcoholic fatty liver and insulin resistance: a cause-effect relationship?}, author={Bugianesi E and Zannoni C and Vanni E and Marzocchi R and Marchesini G}, journal={Dig Liver Dis}, volume={36}, number={3}, pages={165-73}}"}}]}